Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Pharmacogenetics on Treatment Toxicities and Outcomes in East Asian and Caucasian Patients Undergoing Docetaxel or Gemcitabine-based Chemotherapy

NCT00695994 is registered in ClinicalTrials.gov with National University Hospital, Singapore as lead sponsor.

NCT NCT00695994
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00695994 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Pharmacogenetics on Treatment Toxicities and Outcomes in East Asian and Caucasian Patients Undergoing Docetaxel or Gemcitabine-based Chemotherapy
Lead sponsor
National University Hospital, Singapore
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2006
Completion date
September 30, 2012
Enrollment
300 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, non small cell lung cancer